TKS Article: Chemistry 4.0 in pharmaceutical development

"The pharmaceutical industry is being revolutionised by the utilisation of digital technologies. Chemistry 4.0 describes this digital transformation and how its delivery is paving the way for the industry’s next stage of development."

This article explores the range of digital technologies which are now being employed across the drug development pathway. Quotient's Sr. Director of Science & Technology, Gareth Jenkins, and Head of Drug Substance, Paul Quigley, share their insights on Chemistry 4.0 and the digital transformation of the pharmaceutical industry.

You can read the full article here on the TKS Publisher website

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.